OGC
Oak Grove Capital’s Novo Nordisk NVO Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-8,605
| Closed | -$1.02M | – | 64 |
|
2024
Q3 | $1.02M | Sell |
8,605
-11,985
| -58% | -$1.43M | 0.17% | 36 |
|
2024
Q2 | $2.94M | Sell |
20,590
-23,420
| -53% | -$3.34M | 0.53% | 22 |
|
2024
Q1 | $5.65M | Sell |
44,010
-155,666
| -78% | -$20M | 1.14% | 18 |
|
2023
Q4 | $20.7M | Buy |
199,676
+19,190
| +11% | +$1.99M | 5.49% | 5 |
|
2023
Q3 | $16.4M | Buy |
180,486
+86,923
| +93% | +$7.9M | 5.71% | 5 |
|
2023
Q2 | $15.1M | Buy |
93,563
+13,961
| +18% | +$2.26M | 5.18% | 6 |
|
2023
Q1 | $12.7M | Buy |
79,602
+12,582
| +19% | +$2M | 5.18% | 7 |
|
2022
Q4 | $9.07M | Buy |
67,020
+54,221
| +424% | +$7.34M | 4.56% | 7 |
|
2022
Q3 | $1.28M | Buy |
12,799
+10,075
| +370% | +$1M | 0.43% | 34 |
|
2022
Q2 | $304K | Sell |
2,724
-3,279
| -55% | -$366K | 0.1% | 51 |
|
2022
Q1 | $667K | Buy |
+6,003
| New | +$667K | 0.14% | 52 |
|